Sandoz enters into biosimilar partnership with Biocon

22-01-2018

Sandoz enters into biosimilar partnership with Biocon

Choreograph / iStockphoto.com

Germany-based Sandoz has entered into a partnership with Biocon to develop, manufacture and commercialise biosimilars in immunology and oncology.


Sandoz, Biocon, Novartis, Richard Francis, biosimilars, drug development, biopharmaceuticals

LSIPR